CompletedPhase 3NCT00003702
Methotrexate Compared With Dactinomycin in Treating Patients With Gestational Trophoblastic Neoplasia
Studying Gestational trophoblastic neoplasm
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Gynecologic Oncology Group
- Principal Investigator
- Raymond OsborneGynecologic Oncology Group
- Intervention
- Dactinomycin(biological)
- Enrollment
- 240 enrolled
- Eligibility
- FEMALE
- Timeline
- 1999
Study locations (1)
- Gynecologic Oncology Group, Philadelphia, Pennsylvania, United States
Collaborators
Eastern Cooperative Oncology Group · National Cancer Institute (NCI)
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT00003702 on ClinicalTrials.govOther trials for Gestational trophoblastic neoplasm
Additional recruiting or active studies for the same condition.